ArticleCancer immunology, immunotherapy : CII2007

Ii-Key/HER-2/neu(776-790) hybrid peptides induce more effective immunological responses over the native peptide in lymphocyte cultures from patients with HER-2/neu+ tumors.

Nectaria N Sotiriadou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.